Rationale and Study Design to Assess the Efficacy and Safety of Minocycline in Patients with Moderate to Severe Acute Ischaemic Stroke (EMPHASIS)
Background Inflammation and blood-brain barrier disruption may contribute to the pathogenesis of ischaemic stroke. Minocycline was shown to exert anti-inflammatory effects by attenuating microglial activation and protecting blood-brain barrier in preclinical studies. Previous small-scale clinical st...
Saved in:
| Main Authors: | Liping Liu, Yongjun Wang, Yilong Wang, Xingquan Zhao, Yao Lu, Philip M Bath, Xiaoling Liao, Yuesong Pan, S Claiborne Johnston, Pierre Amarenco, Ling Guan, Hui Qu, Luyan Wang, Yicong Wang, Meiyang Zhang, Qianqian Yang, Baoshan Qiu, Dongyang Zhou, Xuejiao Zhou |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
|
| Series: | Stroke and Vascular Neurology |
| Online Access: | https://svn.bmj.com/content/early/2025/03/26/svn-2024-003577.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Relationship Between Neutrophil Count and 90‐Day Outcomes and Effect of Dual Antiplatelet Therapy in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Post Hoc Analysis of the INSPIRES Trial
by: Yicong Wang, et al.
Published: (2025-07-01) -
Cost-effectiveness of ticagrelor plus aspirin versus aspirin in acute ischaemic stroke or transient ischaemic attack: an economic evaluation of the THALES trial
by: Yongjun Wang, et al.
Published: (2023-10-01) -
Efficacy and safety of Y-3 intracalvariosseous injection versus intravenous injection in the treatment of acute large hemispheric infarction (SOLUTION-2): rationale and design of a multicentre, prospective, randomised, open-label, blind endpoint (PROBE) trial
by: Yongjun Wang, et al. -
Dual Antiplatelet Therapy in Patients With Metabolic Syndrome After Mild Ischemic Stroke or Transient Ischemic Attack
by: Zhang Xia, et al.
Published: (2025-08-01) -
Influence of impaired renal function on the outcomes of patients with acute ischaemic stroke treated with intravenous tenecteplase and alteplase: a post hoc analysis of the TRACE-2 trial
by: Yongjun Wang, et al.